Parnell Pharmaceuticals Holdings Ltd Share Price Nasdaq
Equities
AU0000XINEU9
Pharmaceuticals
Sales 2020 | 30M 19.82M 1.65B | Sales 2021 | 34.17M 22.58M 1.88B | Capitalization | 4.08K 2.7K 225K |
---|---|---|---|---|---|
Net income 2020 | -15M -9.91M -827M | Net income 2021 | -1M -661K -55.13M | EV / Sales 2020 | 2.18 x |
Net Debt 2020 | 56.16M 37.11M 3.1B | Net Debt 2021 | 58.89M 38.92M 3.25B | EV / Sales 2021 | 1.72 x |
P/E ratio 2020 |
-0.56
x | P/E ratio 2021 |
-
| Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Brad R. McCarthy
CEO | Chief Executive Officer | 48 | 01/10/01 |
Joe Rosentel
CTO | Chief Tech/Sci/R&D Officer | - | 01/21/01 |
Pablo Lamberto
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jay B. Benear
BRD | Director/Board Member | - | - |
Doug Schillinger
BRD | Director/Board Member | 50 | - |
Eric Moore
BRD | Director/Board Member | - | 21/20/21 |
1st Jan change | Capi. | |
---|---|---|
-15.35% | 76.23B | |
-9.19% | 6.67B | |
-1.11% | 3.21B | |
+6.08% | 1.52B | |
-15.13% | 1.37B | |
-25.63% | 1.24B | |
-7.62% | 1.21B | |
-10.84% | 1.17B | |
-.--% | 1.05B |